PMID: 15375479Sep 18, 2004Paper

Atrial fibrillation after cardiac surgery: pathophysiology and treatment

Seminars in Cardiothoracic and Vascular Anesthesia
Christopher A PalinC W Hogue

Abstract

Atrial fibrillation (AF) occurs in 25% to 60% of patients after cardiac surgery. It is most consistently associated with advanced age and valvular heart operations. Despite improving knowledge of the pathophysiology of chronic AF, postoperative AF remains an obstinate clinical problem. It is associated with an increased risk of stroke, longer hospital stay, and higher hospital expenditure. Consequently, there has been great interest in strategies to prevent and treat this arrhythmia. Treatment for postoperative AF may require immediate electrical cardioversion for hemodynamically unstable patients. Heart rate control is useful in most patients, with anticoagulation considered after 48 hours. Antiarrhythmic therapy is often effective in restoring sinus rhythm but its use needs to be balanced against the patient's risk of proarrhythmic side effects such as torsade de pointes.

References

Jan 1, 1992·Scandinavian Journal of Thoracic and Cardiovascular Surgery·E Hjelms
Sep 1, 1993·The Annals of Thoracic Surgery·L L CreswellJ L Cox
Jan 1, 1995·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·P Di BiasiC Santoli
Mar 7, 1998·Circulation·K T Murray
Sep 3, 1998·The New England Journal of Medicine·M HaïssaguerreJ Clémenty
Aug 10, 1999·Circulation·C W HogueV G Dávila-Román
Nov 11, 1999·Circulation·S J Connolly
Feb 2, 2000·The Annals of Thoracic Surgery·C W Hogue, M L Hyder
Sep 6, 2000·Trends in Biochemical Sciences·M J Sutcliffe, N S Scrutton
Feb 7, 2001·Circulation·M A AllessieA L Waldo
Apr 5, 2001·The New England Journal of Medicine·R H Falk
Jan 29, 2002·Anesthesia and Analgesia·Timothy O StanleyUNKNOWN CARE Investigators of the Duke Heart Center
Nov 19, 2002·JAMA : the Journal of the American Medical Association·Carl van WalravenBeppie Hellemons
Dec 6, 2002·The New England Journal of Medicine·D G WyseUNKNOWN Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators
Dec 24, 2002·Current Opinion in Cardiology·Chin-Feng TsaiShih-Ann Chen
Feb 28, 2003·The Annals of Thoracic Surgery·Thomas SalamonDavid A Brown
Apr 10, 2003·The Annals of Thoracic Surgery·J F Matthias BechtelClaus Bartels

❮ Previous
Next ❯

Citations

Apr 3, 2008·Asian Cardiovascular & Thoracic Annals·Shahzad G Raja, Gilles D Dreyfus
Oct 5, 2016·Aging and Disease·Maureen E CzickDavid I Silverman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.